期刊文献+

细胞焦亡参与肿瘤发生分子机制的研究进展 被引量:5

Advances in the Molecular Mechanism of Pyroptosis Involved in the Occurrence of Tumors
原文传递
导出
摘要 细胞焦亡是一种依赖gasdermin家族蛋白的成孔活性,由半胱氨酸–天冬氨酸特异性蛋白激酶1、4、5、11等介导的以细胞肿胀、质膜穿孔及炎性小分子的释放为特征的新的裂解性、促炎性程序性细胞死亡。目前发现,细胞焦亡参与了多种疾病的发生与发展过程,特别是对肿瘤及肿瘤微环境的形成具有促进及抑制的双重功能,使焦亡成为抗肿瘤药物研究的最新热点之一。该文主要就细胞焦亡在肿瘤发生中的分子机制进行综述,讨论细胞焦亡对肿瘤治疗的意义,以期为肿瘤的靶向治疗提供参考。 Pyroptosis is a new lytic,pro-inflammatory programmed cell death characterized by cell swelling,plasma membrane perforation,and release of inflammatory small molecules.It is a programmed cell death model mediated by cysteine aspartic acid specific protein kinase 1,4,5,11,which mainly depends on the pore-forming activity of Gasdermin protein family.At present,it is found that pyroptosis participates in the occurrence and development of many diseases,especially its dual functions of promoting and inhibiting the formation of tumor and tumor microenvironment.It makes pyroptosis becomes one of the latest hot spots in the research of anti-tumor drugs.In this paper,the molecular mechanism of cell pyrosis in tumorigenesis is reviewed.The significance of pyroptosis in cancer treatment is discussed in order to provide a reference for targeted therapy of tumors.
作者 蒋世彬 赵增阳 张淑静 黄穆杰 李奥 JIANG Shibin;ZHAO Zengyang;ZHANG Shujing;HUANG Mujie;LI Ao(Shandong University of Technology,Zibo 255049,China;Zibo Center for Disease Control and Prevention,Zibo 255026,China)
出处 《中国细胞生物学学报》 CAS CSCD 2021年第1期194-200,共7页 Chinese Journal of Cell Biology
基金 国家自然科学基金(批准号:31701845) 山东省国家自然科学基金(批准号:ZR2017BC005) 山东省传染病预防控制重点实验室开放课题(批准号:2017KEYLAB06) 山东省医药卫生科技发展计划(批准号:2015WS0007)资助的课题。
关键词 细胞焦亡 促炎性程序性细胞死亡 炎性小体 肿瘤 分子机制 pyroptosis pro-inflammatory programmed cell death inflammasome tumors molecular mechanism
  • 相关文献

参考文献5

二级参考文献47

  • 1Zheng, Yao,Wang, Lin,Zhang, Jian-Ping,Yang, Jing-Yan,Zhao, Zhu-Mei,Zhang, Xiao-Ying.Expression of p53,c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma[J].World Journal of Gastroenterology,2010,16(3):339-344. 被引量:34
  • 2Xiao-Jun Liu,Zhao-Feng Chen,Hai-Long Li,Ze-Nan Hu,Min Liu,Ai-Ping Tian,Da Zhao,Jing Wu,Yong-Ning Zhou,Liang Qiao.Interaction between cyclooxygenase-2,Snail,and E-cadherin in gastric cancer cells[J].World Journal of Gastroenterology,2013,19(37):6265-6271. 被引量:8
  • 3孙乔,张令强,贺福初.GSDMDC家族的基因功能[J].遗传,2006,28(5):596-600. 被引量:3
  • 4TakanoriMaruyama,YoshikiMizukami,YoshihikoKawaguchi,KousakuMimura,MitsuakiWatanabe,ShinichirouIzawa,HidekiFujii.Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor‐infiltrating lymphocytes, tumor‐draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer[J]. Cancer Science . 2010 (9)
  • 5Hazel Tye,Catherine L. Kennedy,Meri Najdovska,Louise McLeod,William McCormack,Norman Hughes,Anouk Dev,William Sievert,Chia Huey Ooi,Tomo-o Ishikawa,Hiroko Oshima,Prithi S. Bhathal,Andrew E. Parker,Masanobu Oshima,Patrick Tan,Brendan J. Jenkins.STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation[J]. Cancer Cell . 2012 (4)
  • 6Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. The Lancet . 2010 (9742)
  • 7Donald Richards,Darren M. Kocs,Alexander I. Spira,A. David McCollum,Sami Diab,Lanny I. Hecker,Allen Cohn,Feng Zhan,Lina Asmar.Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomized phase 2 study[J].European Journal of Cancer.2013
  • 8Terence C.Chua,Neil D.Merrett.Clinicopathologic factors associated with HER2‐positive gastric cancer and its impact on survival outcomes—A systematic review[J].Int J Cancer.2012(12)
  • 9P.Allavena,A.Mantovani.Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment[J].Clinical & Experimental Immunology.2012(2)
  • 10Heike Grabsch,Shivan Sivakumar,Sally Gray,Helmut E. Gabbert,Wolfram Müller.HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series[J].Cellular Oncology (-).2010(1-2)

共引文献1051

同被引文献70

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部